Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea · Delayed Price · Currency is KRW 3,655.00
-45.00 (-1.22%)
At close: Apr 20, 2026
Korea Arlico Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -605.35 | -5,358 | 3,061 | 8,034 | 4,930 |
Depreciation & Amortization | 4,932 | 6,615 | 4,772 | 3,113 | 2,606 |
Loss (Gain) From Sale of Assets | 58.69 | -392.92 | -9.08 | 313.88 | -964.68 |
Loss (Gain) From Sale of Investments | -90.46 | -240.36 | -190.71 | -168.93 | -30.37 |
Stock-Based Compensation | - | - | - | - | 40.17 |
Provision & Write-off of Bad Debts | -50.84 | 1,390 | 126.29 | 237.65 | -10.88 |
Other Operating Activities | 2,181 | 1,132 | -1,585 | 984.83 | 889.17 |
Change in Accounts Receivable | 2,421 | -9,102 | -2,604 | -827.32 | -81.67 |
Change in Inventory | -337.57 | -6,475 | 987.01 | -7,508 | -2,018 |
Change in Accounts Payable | -1,053 | 2,474 | 44.89 | -305.18 | 1,746 |
Change in Other Net Operating Assets | 2,538 | 1,373 | 2,545 | 962.68 | 1,861 |
Operating Cash Flow | 9,995 | -8,583 | 7,148 | 4,836 | 8,967 |
Operating Cash Flow Growth | - | - | 47.80% | -46.07% | 97.25% |
Capital Expenditures | -3,112 | -3,501 | -23,385 | -18,974 | -5,268 |
Sale of Property, Plant & Equipment | 110.73 | 1,029 | 9.11 | 45.95 | 43.43 |
Sale (Purchase) of Intangibles | -1,886 | -78.8 | -135.15 | -3,434 | 352.82 |
Investment in Securities | 2,386 | 8,432 | -3,622 | 13,742 | -7,737 |
Other Investing Activities | -135.21 | -46.55 | -117.48 | -299.48 | 6,471 |
Investing Cash Flow | -2,636 | 4,834 | -27,250 | -8,919 | -6,137 |
Short-Term Debt Issued | 21,685 | 47,898 | 56,109 | 5,796 | 2,826 |
Long-Term Debt Issued | 754 | 2,000 | 12,998 | 13,633 | - |
Total Debt Issued | 22,439 | 49,898 | 69,107 | 19,429 | 2,826 |
Short-Term Debt Repaid | -22,817 | -36,738 | -49,218 | - | - |
Long-Term Debt Repaid | -2,018 | -10,776 | -2,179 | -342.25 | -95.02 |
Total Debt Repaid | -24,836 | -47,514 | -51,398 | -342.25 | -95.02 |
Net Debt Issued (Repaid) | -2,396 | 2,384 | 17,710 | 19,087 | 2,731 |
Repurchase of Common Stock | - | - | - | - | -566.07 |
Dividends Paid | -1,126 | -1,952 | -1,952 | -1,051 | -957.6 |
Other Financing Activities | - | -270 | - | 19 | -56.34 |
Financing Cash Flow | -3,522 | 162.53 | 15,758 | 18,055 | 1,151 |
Foreign Exchange Rate Adjustments | -8.49 | 4.54 | 15.39 | -96.27 | 32.47 |
Net Cash Flow | 3,828 | -3,582 | -4,329 | 13,876 | 4,013 |
Free Cash Flow | 6,883 | -12,085 | -16,237 | -14,137 | 3,699 |
Free Cash Flow Margin | 3.42% | -6.35% | -8.68% | -8.43% | 2.64% |
Free Cash Flow Per Share | 454.81 | -805.18 | -963.66 | -936.13 | 245.38 |
Cash Interest Paid | 1,465 | 1,493 | 807.52 | 599.28 | 278.98 |
Cash Income Tax Paid | -36.96 | 548.79 | 1,565 | 758.08 | 1,758 |
Levered Free Cash Flow | 1,909 | -14,241 | -19,870 | -16,738 | 2,647 |
Unlevered Free Cash Flow | 3,256 | -12,926 | -18,878 | -16,133 | 2,820 |
Change in Working Capital | 3,570 | -11,730 | 973.18 | -7,678 | 1,508 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.